408 related articles for article (PubMed ID: 28929865)
1. False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making.
Pinsky PF; Bellinger CR; Miller DP
J Med Screen; 2018 Jun; 25(2):110-112. PubMed ID: 28929865
[TBL] [Abstract][Full Text] [Related]
2. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
[TBL] [Abstract][Full Text] [Related]
3. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
4. Incidental renal tumours on low-dose CT lung cancer screening exams.
Pinsky PF; Dunn B; Gierada D; Nath PH; Munden R; Berland L; Kramer BS
J Med Screen; 2017 Jun; 24(2):104-109. PubMed ID: 28482765
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
[TBL] [Abstract][Full Text] [Related]
6. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
[TBL] [Abstract][Full Text] [Related]
7. Screening for Lung Cancer: Lexicon for Communicating With Health Care Providers.
Carter BW; Lichtenberger JP; Wu CC; Munden RF
AJR Am J Roentgenol; 2018 Mar; 210(3):473-479. PubMed ID: 29261349
[TBL] [Abstract][Full Text] [Related]
8. Effective use of low-dose computed tomography lung cancer screening.
Jeffers CD; Pandey T; Jambhekar K; Meek M
Curr Probl Diagn Radiol; 2013; 42(5):220-30. PubMed ID: 24070715
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
[TBL] [Abstract][Full Text] [Related]
10. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
[TBL] [Abstract][Full Text] [Related]
11. Adherence to annual lung cancer screening with low-dose CT scan in a diverse population.
Erkmen CP; Dako F; Moore R; Dass C; Weiner MG; Kaiser LR; Ma GX
Cancer Causes Control; 2021 Mar; 32(3):291-298. PubMed ID: 33394208
[TBL] [Abstract][Full Text] [Related]
12. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer screening: Current status and perspective.
Chassagnon G; Revel MP
Diagn Interv Imaging; 2016 Oct; 97(10):949-953. PubMed ID: 27527243
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Lung-RADS in Reducing False-Positive Results in a Diverse, Underserved, Urban Lung Cancer Screening Cohort.
Kaminetzky M; Milch HS; Shmukler A; Kessler A; Peng R; Mardakhaev E; Bellin EY; Levsky JM; Haramati LB
J Am Coll Radiol; 2019 Apr; 16(4 Pt A):419-426. PubMed ID: 30146484
[TBL] [Abstract][Full Text] [Related]
15. Computed tomography screening for lung cancer.
Boiselle PM
JAMA; 2013 Mar; 309(11):1163-70. PubMed ID: 23512063
[TBL] [Abstract][Full Text] [Related]
16. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
Pinsky P; Gierada DS
Lung Cancer; 2020 Jan; 139():179-184. PubMed ID: 31812129
[TBL] [Abstract][Full Text] [Related]
17. The importance of lung cancer screening with low-dose computed tomography for Medicare beneficiaries.
Wood DE
JAMA Intern Med; 2014 Dec; 174(12):2016-8. PubMed ID: 25317992
[TBL] [Abstract][Full Text] [Related]
18. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
[TBL] [Abstract][Full Text] [Related]
19. The effect of different radiological models on diagnostic accuracy and lung cancer screening performance.
Marshall HM; Zhao H; Bowman RV; Passmore LH; McCaul EM; Yang IA; Fong KM
Thorax; 2017 Dec; 72(12):1147-1150. PubMed ID: 28331076
[TBL] [Abstract][Full Text] [Related]
20. A National Survey of Pulmonologists' Views on Low-Dose Computed Tomography Screening for Lung Cancer.
Iaccarino JM; Clark J; Bolton R; Kinsinger L; Kelley M; Slatore CG; Au DH; Wiener RS
Ann Am Thorac Soc; 2015 Nov; 12(11):1667-75. PubMed ID: 26368003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
